In mice bearing HCC827-GR-T790M xenografts (harboring endogenous EGFR Del19, exogenous EGFR T790M, and METamp), monotherapy with tepotinib or rociletinib only moderately affected tumor growth, whereas afatinib and erlotinib had no effect. Here, EGFR is linked to neoplasm.